Category: Elekta AB
Elekta's next-generation Versa HD linear accelerator aims to provide faster and more efficient tumor targeting.
Atlanta medical device company Elekta (STO:EKTA B) this week announced FDA clearance for its Versa HD linear accelerator, allowing the company to move forward with shipping and installations.
McKesson agrees to pony up more than $2 billion for medical supplies provider PSS World Medical.
McKesson (NYSE:MCK) agreed to pay $29 per share for PSS World Medical (NSDQ:PSSI) and its medical supplies business in a deal worth $2.1 billion.
Global medical device company Elekta won Japanese regulatory approval for its Agility radiation therapy system, which boasts twice as many beam-shaping tungsten leaves as typical systems.
Global medical device company Elekta (STO:EKTA B) won Japanese regulatory approval for its Agility radiation therapy system, which promises "faster, more accurate cancer treatments on the horizon."
Analysts foresee a stable, and possibly improving, road ahead for the U.S. orthopedics market as bellwether Biomet releases preliminary Q2 earnings showing strong growth in knee and hip devices.
Things are looking up for the U.S. orthopedics market, as preliminary results for Biomet Inc.'s 2nd quarter suggest strong growth in domestic knee and hip devices sales.
Privately held Biomet, considered something of a bellwether for the U.S. orthopedics market, touted 6% year-over-year growth in knees and 8% in hips.
The FDA lets Cooper Cos. put its recalled Avaira Toric contact lenses back on the U.S. market; also, Delcath Chemsat component wins CE Mark; Elekta lands CE Mark for beam-shaper; new Steris product gets new device category, 510(k); Anulex touts expanded fiXate clearance; Fenwal wins 510(k) for plasma exchange protocol; Devon Medical's NPWT device wins FDA nod; Navidea wins Lymphoseek extension; and Estech gets conditional IDE for ATTAC-AF trial.
Cooper Cos. (NYSE:COO) today announced that the U.S. Food and Drug Administration has granted a Special 510(k) clearance for CooperVision's Avaira Toric two-week silicone hydrogel contact lenses for astigmatism.
CooperVision will re-launch Avaira Toric with shipments available for select distribution beginning in early May 2012.
